Latigo Biotherapeutics Inc

LTGO

Insiders bought in the last twelve months.

13.98 0.78 −5.28%
Market cap
$978.6M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Dec '25
Cash and Short Term Investments
55.20 69.63
Total current assets
59.20 73.83
Property, Plant, Equpment (Net)
0.46 0.45
Long-term assets (Other)
3.80 0.62
Total non-current assets
5.56 1.69
Total Assets
64.76 75.52
Notes Payable
29.90 —
Accounts Payable
3.57 5.02
Accrued Expenses
12.26 12.87
Other current liabilities
5.15 —
Total current liabilities
51.58 18.45
Non-current Liabilities (Other)
0.04 0.04
Total non-current liabilities
0.68 0.16
Total liabilities
52.26 18.61
Additional Paid In Capital
15.81 11.46
Preferred Stock (Total)
288.58 288.58
Retained Earnings
(291.89) (243.13)
Common Equity (Total)
(276.08) (231.67)
Shareholders Equity (Total)
12.50 56.91
Shareholders Equity and Liabilities (Total)
64.76 75.52
Shares (Common)
0.99 0.88
Shares (Preferred)
41.16 41.16
Shareholders Equity (Tangible)
12.50 56.91
Net Debt
(55.20) (69.63)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 29 Sep 2026